No Data
Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders
Even though Pacific Biosciences of California, Inc. (NASDAQ:PACB) has fallen by 12% over the past week , insiders who sold US$3.1m worth of stock over the past year have had less luck. Insiders might
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human Disease ResearchMENLO PARK, Calif., June 10, 2024 /PRNewswire/ -- PacBio
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB) in the last three months.The table below summarizes their rec
Express News | Jefferies Initiates Coverage On Pacific Biosciences With Buy Rating, Announces Price Target of $4
Express News | Pacific Biosciences of California Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $4
Reasons to Retain PacBio (PACB) Stock in Your Portfolio